TGA Issues Two Device Market Actions in October 2026: Care Bed Handset Lacks Auto-Lock and Puncture Needle Pack Contains Another Model

TGA Issues Two Device Market Actions in October 2026

In October 2026, the Australian Therapeutic Goods Administration (TGA) published two medical device market actions on its website. On 6 October, it announced a product correction for the KayserBetten Safe Surround Genie Bed care bed, executed by Australian sponsor Medifab. From 20 October, it implemented a recall of one lot of Cook EchoTip Ultra high-definition ultrasound access needles, involving five devices in a pack. Both actions were limited in scale, but the issues were specific: one device could be moved through inadvertent operation when unattended, and one pack contained a different model while all labels were identical.

The scope, classification and implementation requirements of both actions are subject to the original TGA notices. This article summarises what companies should verify based on the public records.

Care Bed: Handset Does Not Automatically Lock After Use

The notice states that the Safe Surround Genie Bed is a care bed designed for children and adults requiring additional protection, because users may move into unsafe positions at night. The issue concerns the handset: the original model does not automatically lock after use. If the bed is left unattended and the handset is not locked with a key, another person may inadvertently operate the handset and move the bed. TGA states that the potential consequence is entrapment, which may cause serious injury or death. The notice also states that two deaths have been reported overseas; to date, no related incidents have been reported in Australia.

The affected scope is narrow: ARTG number 151342, product code 7959-0016-000, and manufacture on or before 9 July 2025. The scope ends there. The issue relates only to that handset configuration and does not affect the entire bed range.

Temporary Safety Measures Before Replacement

The corrective action is to replace the original handset with a model featuring automatic locking, with Medifab arranging appointments for replacement. Until the new handset is installed, the notice requires three temporary measures when the bed is unattended:

• Adjust the sleeping platform to the horizontal position and lower it to the lowest height;
• Lock all handset functions with the key;
• Close the bed doors.

The notice also requires these measures to be communicated to family members, carers, healthcare professionals and anyone else who may operate the bed.

These three measures deserve separate attention. Until replacement is completed, they are the only means of maintaining safety. For companies exporting similar care beds and rehabilitation beds, this section is effectively a free design review checklist: default locking, locked-status indication, and behaviour after power loss or inadvertent activation are all design inputs for the user-absent scenario.

Puncture Needle: One of Five in a Pack Was Another Model

The second action is the Cook recall, TGA action number RC-2026-RN-00833-1. The product is the EchoTip Ultra high-definition ultrasound access needle, model ECHO-HD-19-A, lot C2415199, ARTG number 163822. TGA describes the issue as product identification inconsistency: all five devices in the lot were labelled ECHO-HD-19-A, but one device was actually an EchoTip ClearCore, model ECHO-BX-22, lot C2416756. Because it is not possible to identify the mispackaged device from the label, all five were recalled on a precautionary basis.

The record classifies the action as a recall, hazard classification Class III, action level Hospital, effective from 20 October 2026, with William A Cook Australia Pty Ltd as the responsible entity. The potential harm stated in the notice is temporary discomfort from mucosal irritation or minor mucosal injury, or perforation causing self-limiting bleeding that requires management during the procedure. As of publication, Cook had not received patient injury complaints related to the mispackaged device. Customers are required to take two actions: quarantine the product and stop further distribution and use; and complete the customer response form and return the product to Cook to obtain product credit.

How to Read the Classification

TGA's recall procedure document (PRAC) divides market actions into three classes. Class I is critical safety: there is a reasonable probability of serious injury or death, and the customer letter title must include Critical. Class II is urgent safety: the issue may cause temporary or minor injury, or the probability of serious injury or death is low, and the title must include Urgent. Class III is lowest risk: the issue is unlikely to cause injury, or the probability of temporary or minor injury is low.

Under this framework, the Cook lot requires retrieval, documentation and collection of each customer's response. It has not reached the level of immediately stopping all similar consumables. By contrast, although no classification field is shown in this record for the care bed action, the notice directly refers to two deaths overseas, and the magnitude of the risk description is entirely different. Viewed together, the two actions show that the classification of a market action depends on the combination of harm consequence and likelihood, not on recall quantity.

Three Items Exporting Manufacturers Should Verify

• Model verification in the packaging process. One different model was mixed into a five-unit pack of the same model. Upstream, assembly error-proofing failed; downstream, the label could not perform a differentiating function. Lot segregation, unit-by-unit barcode verification and model confirmation before packing are often described only briefly in registration files, but they translate directly into recall costs after market entry.
• Default safety in the use scenario. The care bed problem is not a component issue. The root cause is a design assumption: safety is left to manual locking by the user. That assumption does not hold in real care environments. For such products, automatic locking, status indication and mechanical restriction of abnormal movement are more effective than bold warnings in the instructions for use.
• Documentation of recall response. In the Cook action, customers must sign a response form before receiving credit. The TGA record sets out the effective date, responsible entity, ARTG and UDI. For companies, such records may be reviewed in later audits, applications for similar products and distributor relationships.

Sources and Scope of Verification

Source: Australian Therapeutic Goods Administration (TGA) market action page, KayserBetten Safe Surround Genie Bed (published 6 October 2026): https://www.tga.gov.au/safety/recalls-and-other-market-actions/market-actions/kayserbetten-safe-surround-genie-bed

Source: TGA recall database record, EchoTip Ultra with High-Definition Ultrasound Access Needle, action number RC-2026-RN-00833-1 (action start date 20 October 2026): https://apps.tga.gov.au/PROD/DRAC/arn-detail.aspx?k=RC-2026-RN-00833-1

Source: TGA procedure for recalls, product alerts and product corrections (PRAC), page last updated 24 February 2026 as shown: https://www.tga.gov.au/safety/recalls-and-other-market-actions/procedure-recalls-product-alerts-and-product-corrections-prac

Verification scope and access date: the three official TGA pages above were reviewed, and product names, models, lot numbers, ARTG numbers, classifications, action levels, effective dates and disposition requirements were compared line by line. Access date: 27 October 2026.

Application note: this article interprets publicly available regulatory information from TGA and does not constitute a conclusion or commitment regarding any specific product, company or registration application. The classifications, scope and disposition requirements in this article are subject to the original TGA text; official pages may change with subsequent updates, and original records should be consulted directly for specific products.

AIMEILI Regulatory Interpretation

For global device manufacturers, the two actions illustrate two distinct post-market risk pathways: a design-related field correction and a packaging and labelling-related lot recall. The care bed action is a product correction rather than a recall, but the underlying risk is severe because the design assumes manual locking in an unattended setting. Regulatory teams should test whether similar assumptions appear in their own risk management files, particularly for home-use and long-term care devices where the operator may not be the patient and may change between shifts. Design controls should address default lockout, clear locked and unlocked status, behaviour after power interruption and mechanical limits on unintended movement. If the residual risk depends on user action, the instructions for use and training materials alone may not be sufficient.

The Cook action shows how a packaging error can become a recall even when the potential harm is classified as Class III. Because the mispackaged unit could not be identified from the label, the entire five-unit pack was recalled. For manufacturers, this reinforces the need to treat model and lot verification as a critical control point at packing. Barcode or UDI verification at unit level, physical segregation of similar models and line clearance records are useful evidence of control. Sponsors and distributors should also maintain distribution records that allow rapid quarantine and customer response collection.

Business Impact

For care bed and rehabilitation bed exporters, the KayserBetten action is a practical design and field-action benchmark. A handset that does not automatically lock can lead to a correction campaign, on-site replacement scheduling and communication with carers and healthcare professionals. Companies should review handset behaviour, lock indication, instructions and service arrangements before similar issues arise in export markets. The cost of a field correction is usually much higher than the cost of design verification at the development stage.

For manufacturers of needles, catheters and other sterile consumables, mixed-model packs present a direct recall and credit-return burden. Even a Class III recall requires lot quarantine, customer notification, response forms and returned product handling. Exporters should verify that packaging lines can distinguish similar models and that labels, instructions for use and UDI data remain aligned with the actual contents. Distributors should be prepared to identify affected customers quickly and to document the stop-use and return process.

For CROs and regulatory affairs teams, the TGA records provide a useful reference for recall classification and action levels. Class I, II and III are not determined by the number of units affected but by the severity and likelihood of harm. A small lot can still require urgent action if the potential consequence is serious, while a larger correction may be handled at hospital level if the risk is limited. Maintaining a recall readiness procedure, including customer response templates, traceability and regulatory notification steps, will reduce response time and support future inspections and product applications.